8-K/AThe WireRoutine
Company Update
Filed Mar 22, 2016 · 10y ago · Accession 0001193125-16-513640
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- 8-K/A
- Filing date
- Mar 22, 2016
- Report date
- Jan 8, 2016
- Document
- d137565d8ka.htm
- Size
- 475 KB